These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2857053)

  • 1. Effects of cyclic hexapeptide analog of somatostatin on pancreatic secretion in dogs.
    Konturek SJ; Cieszkowski M; Bilski J; Konturek J; Bielanski W; Schally AV
    Proc Soc Exp Biol Med; 1985 Jan; 178(1):68-72. PubMed ID: 2857053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of somatostatin and its highly potent hexa- and octapeptide analogs on exocrine and endocrine pancreatic secretion.
    Konturek SJ; Bilski J; Jaworek J; Tasler J; Schally AV
    Proc Soc Exp Biol Med; 1988 Feb; 187(2):241-9. PubMed ID: 2448802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin.
    Konturek SJ; Konturek JW; Lamers CB; Tasler J; Bilski J
    Int J Pancreatol; 1987 Aug; 2(4):223-35. PubMed ID: 2890695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin-secretin or by a test meal in the dog.
    Kayasseh L; Gyr K; Stalder GA; Rittmann WW; Girard J
    Horm Res; 1978; 9(3):176-84. PubMed ID: 640582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of neurotensin and fat on pancreatic stimulation in dogs.
    Konturek SJ; Jaworek J; Cieszkowski M; Pawlik W; Kania J; Bloom SR
    Am J Physiol; 1983 Jun; 244(6):G590-8. PubMed ID: 6305210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the inhibition of pancreatic secretion by luminal somatostatin.
    Konturek SJ; Tasler J; Cieszkowski M; Jaworek J; Arimura A; Schally AV
    Am J Physiol; 1981 Aug; 241(2):G109-15. PubMed ID: 6115584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats.
    Jyotheeswaran S; Li P; Chang TM; Chey WY
    Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion.
    Konturek SJ; Tasler J; Obtulowicz W; Coy DH; Schally AV
    J Clin Invest; 1976 Jul; 58(1):1-6. PubMed ID: 932201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pancreatic polypeptide and its C-terminal hexapeptide on meal and secretin induced pancreatic secretion in dogs.
    Chance RE; Cieszkowski M; Jaworek J; Konturek SJ; Swierczek J; Tasler J
    J Physiol; 1981 May; 314():1-9. PubMed ID: 7310683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs.
    Misumi A; Shiratori K; Lee KY; Barkin JS; Chey WY
    Surgery; 1988 Apr; 103(4):450-5. PubMed ID: 2895501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of pancreatic polypeptide on exocrine pancreas and on release of cholecystokinin and secretin.
    Lonovics J; Guzman S; Devitt PG; Hejtmancik KE; Suddith RL; Rayford PL; Thompson JC
    Endocrinology; 1981 May; 108(5):1925-30. PubMed ID: 7215307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)].
    Creutzfeldt W; Lankisch PG; Fölsch UR
    Dtsch Med Wochenschr; 1975 May; 100(20):1135-8. PubMed ID: 1126301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual actions of glucagon: direct stimulation and indirect inhibition of dog pancreatic secretion.
    Horiuchi A; Iwatsuki K; Ren LM; Kuroda T; Chiba S
    Eur J Pharmacol; 1993 Jun; 237(1):23-30. PubMed ID: 7689468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of substance P on pancreatic exocrine secretion stimulated by secretin, dopamine and cholecystokinin in dogs.
    Iwatsuki K; Yamagishi F; Chiba S
    Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):663-70. PubMed ID: 2433085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enkephalin inhibits the release and action of secretin on pancreatic secretion in the dog.
    Chey WY; Coy DH; Konturek SJ; Schally AV; Tasler J
    J Physiol; 1980 Jan; 298():429-36. PubMed ID: 7359425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth hormone releasing factor on pancreatic secretion in vivo and in vitro.
    Konturek SJ; Bilski J; Jaworek J; Mochizuki T; Yanaihara C; Yanaihara N
    Regul Pept; 1989 Mar; 24(3):301-11. PubMed ID: 2469109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentiating effect of secretin on cholecystokinin-stimulated exocrine pancreatic secretion in rats].
    Moriyoshi Y
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2425-33. PubMed ID: 2480464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
    Shiratori K; Watanabe S; Takeuchi T
    Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEK inhibits secretin release and pancreatic secretion: roles of secretin-releasing peptide and somatostatin.
    Li JP; Lee KY; Chang TM; Chey WY
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G890-6. PubMed ID: 11292597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of natural peptide YY on pancreatic secretion and cholecystokinin release in conscious dogs.
    Hosotani R; Inoue K; Kogire M; Tatemoto K; Mutt V; Suzuki T; Rayford PL; Tobe T
    Dig Dis Sci; 1989 Mar; 34(3):468-73. PubMed ID: 2920652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.